Quantitative determination of citalopram hydrobromide by spectro-photometry and chemometry in presence of its degradation products and additivesin pharmaceutical preparation

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorM. El-Maraghy, Christine
dc.contributor.authorM. Amer, Sawsan
dc.contributor.authorSalem, Hesham
dc.contributor.authorNebsen, Marianne
dc.date.accessioned2020-02-09T08:41:50Z
dc.date.available2020-02-09T08:41:50Z
dc.date.issued2016
dc.descriptionMSA Google Scholaren_US
dc.description.abstractSimple, accurate, sensitive and validated UV stability-indicating spectro- photometric and chemometric methods were developed for determination of Citalopram Hydrobromide (CT) in presence of its alkaline, oxidative degradation products and in its pharmaceutical preparation. Method (A) is a successive derivative ratio spectrophotometricone, which depends on the successive derivative ofratio spectra in two steps and measuring Citalopram Hydrobromide at 277nm and 293nm. Method (B) is mean centering of ratio spectra which dependson using the mean centered ratio spectra in two successive steps and measuring the mean centeredvalues of the second ratio spectra at 237nm and method (C) used two chemometric techniques ; principal component regression(PCR) and partial least-squares (PLS). The proposed methods werechecked using laboratory-prepared mixtures and were successfully applied for the analysis of pharmaceuticalformulation containing Citalopram Hydrobromide. The proposed methods were vali- dated according to the ICH guidelines. The obtained results were statisti- cally compared with those obtained froma compendial HPLC method,showing no significant difference with respect to accuracy and precision.en_US
dc.description.sponsorshipAnalytical Chemistry: An Indian Journalen_US
dc.identifier.citation[1] P.Baumann; International Clinical Psychopharma- cology, 11, (1996). [2] J.Menegola, M.Steppe, E.E.S.Schapoval;J.AOAC Int., 91, (2008). [3] J.Macek, P.Ptacek J.Kima; J.Chromatogr.B, 755, (2001). [4] HPLC method supplied by SEDICO company through personal communication. [5] B.Narayana, K.Veena; J.Mex.Chem.Soc., 54, (2010). [6] A.Raza; Chem.Pharm.Bull., 54, (2006). [7] I.A.Darwish, I.H.Refaat; J.AOAC Int., 89, (2006). [8] T.G.Halvorsen, S.Pedersen-Bjergaard, K.E.Rasmussen;J.Chromatogr.A, 909, (2001). [9] Z.Rong, X.Shangyou, X.Hongmei, H.Rui, X.Zhining; Chin.j.Anal.chem., 34, (2006). [10] J.J.B.Nevado, C.G.Cabanillas, M.J.V.Llerena, V.R.Robledo;J.Chromatogr.A, 1072, (2005). [11] S.R.Dhaneshwar, M.V.Mahadik; J.AOAC Int., 92, (2009). [12] R.N.Rao, A.N.Raju, R.Narsimha; J.Sep.Sci., 31, (2008). [13] M.Sharma, P.R.Jawa, R.S.Gill, G.Bansal; J.Braz.Chem.Soc., 22, (2011). [14] A.Afkhami, M.Bahram; Spectrochim Acta A Mol Biomol Spectrosc, 61, (2005). [15] A.Afkhami, M.Bahram; Talanta, 66, (2005). [16] E.DinÁ, ÷.‹st¸ndað; Il Farmaco, 58, (2003). [17] R.G.Brereton;Analyst, 122, (1997). [18] H.W.Darwish, S.A.Hassan, M.Y.Salem, B.A.El- Zeiny; SpectrochimActaAMol Biomol Spectrosc, 83, (2011). [19] ICHóInternational Conference on Harmonization, of Technical Requirementsfor registration of Phar- maceuticalsfor Human Use Topic Q2 (R1), Validation of Analytical Procedures; Text and Methodol- ogy, Geneva, Switzerland, (2005). [20] R.Kramer; Chemometric Techniques for Quantitative analysis, Marcel dekker; New York, (1998). [21] F.Navarro-Villosalade,L.V.Prez-Arrbas, M.E.Leon- Gonzalez, L.M.Polo-Diez; Anal.Chim.Acta, 313, (1995). [22] K.R.Beebe,R.J.Pell, M.B.Seashlotz;Chemometrics, APractical Guide,JohnWiley, Sons,Inc., NewYork, (1998).en_US
dc.identifier.doihttps://doi.org/
dc.identifier.issn0974-7419
dc.identifier.otherhttps://doi.org/
dc.identifier.urihttps://t.ly/bR7D1
dc.language.isoenen_US
dc.publisherAnalytical Chemistry: An Indian Journalen_US
dc.relation.ispartofseriesACAIJ;Volume: 16 Issue: 2 Pages: 53-62
dc.subjectUniversity of Citalopram hydrobromide; Degradation; Stability-indicating; Successive derivative ratio; Mean centering of ratio spectra; Chemometricsen_US
dc.titleQuantitative determination of citalopram hydrobromide by spectro-photometry and chemometry in presence of its degradation products and additivesin pharmaceutical preparationen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Faculty Of Pharmacy Research Paper
Loading...
Thumbnail Image
Name:
Ereprint_ACAIJ_3939acceptedpaper.pdf
Size:
489.33 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: